Cautionary optimism: caffeine and Parkinson’s disease risk
Sokol, Leonard L.
Young, Michael J.
Espay, Alberto J.
Postuma, Ronald B.
MetadataShow full item record
CitationSokol, Leonard L., Michael J. Young, Alberto J. Espay, and Ronald B. Postuma. 2016. “Cautionary optimism: caffeine and Parkinson’s disease risk.” Journal of Clinical Movement Disorders 3 (1): 7. doi:10.1186/s40734-016-0037-8. http://dx.doi.org/10.1186/s40734-016-0037-8.
AbstractMost Parkinson’s disease (PD) patients present without known family history and without a diagnosed prodromal phase, underscoring the difficulty of employing primary (neuroprevention) and secondary (neuroprotection) preventions. In cases of monogenic forms, however, potential gene-carrying family members of a proband could engage in neuroprevention, such as exercise or diet modifications, to attenuate the risk of, or delay, disease development. However, a historical lack of recognized disease-modifying interventions has limited clinicians’ ability to recommend reliable preventive measures in caring for at-risk populations. We briefly analyze the first retrospective study to examine caffeine consumption and PD risk in a LRRK2 R1628P cohort.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:27662145
- HMS Scholarly Articles